{
    "response": "Investigations should first define the presence and characteristics of a right midbrain lesion and distinguish vascular, demyelinating, neoplastic or granulomatous aetiologies, while also assessing vascular risk factors and potentially reversible metabolic or infectious contributors before initiating targeted therapy.\n\ninvestigations = [\"MRI brain with and without gadolinium contrast including thin-slice brainstem sequences\", \"Magnetic resonance angiography of intracranial and neck vessels\", \"Non-contrast CT brain\", \"Full blood count\", \"Urea and electrolytes\", \"Liver function tests\", \"Coagulation screen\", \"C-reactive protein\", \"Erythrocyte sedimentation rate\", \"Blood glucose\", \"HbA1c\", \"Fasting lipid profile\", \"Vitamin B12\", \"Folate\", \"Thyroid function tests\", \"HIV serology\", \"Syphilis serology (VDRL and TPHA)\", \"Antinuclear antibody\", \"Anti-neutrophil cytoplasmic antibodies\", \"Serum angiotensin-converting enzyme level\", \"Aquaporin-4 antibody\", \"Myelin oligodendrocyte glycoprotein (MOG) antibody\", \"Lumbar puncture with CSF analysis including cell count, protein, glucose, oligoclonal bands and cytology\", \"Visual evoked potentials\", \"CT scan of chest, abdomen and pelvis with contrast\"]"
}